Department of Neurology, Hospital of Merano (SABES-ASDAA), Merano, Italy.
Department of Internal Medicine, Hospital of Santorso (AULSS-7), Santorso, Italy.
Epilepsia. 2022 Oct;63(10):2507-2518. doi: 10.1111/epi.17372. Epub 2022 Aug 23.
This study was undertaken to validate the accuracy of the Epidemiology-Based Mortality Score in Status Epilepticus (EMSE) in predicting the risk of death at 30 days in a large cohort of patients with status epilepticus (SE) using a machine learning system.
We included consecutive patients with SE admitted from 2013 to 2021 at Modena Academic Hospital. A decision tree analysis was performed using the 30-day mortality as a dependent variable and the EMSE predictors as input variables. We evaluated the accuracy of EMSE in predicting 30-day mortality using the area under the receiver operating characteristic curve (AUC ROC), with 95% confidence interval (CI). We performed a subgroup analysis on nonhypoxic SE.
A total of 698 patients with SE were included, with a 30-day mortality of 28.9% (202/698). The mean EMSE value in the entire population was 57.1 (SD = 36.3); it was lower in surviving compared to deceased patients (47.1, SD = 31.7 vs. 81.9, SD = 34.8; p < .001). The EMSE was accurate in predicting 30-day mortality, with an AUC ROC of .782 (95% CI = .747-.816). Etiology was the most relevant predictor, followed by age, electroencephalogram (EEG), and EMSE comorbidity group B. The decision tree analysis using EMSE variables correctly predicted the risk of mortality in 77.9% of cases; the prediction was accurate in 85.7% of surviving and in 58.9% of deceased patients within 30 days after SE. In nonhypoxic SE, the most relevant predictor was age, followed by EEG, and EMSE comorbidity group B; the prediction was correct in 78.9% of all cases (89.6% in survivors and 46.1% in nonsurvivors).
This validation study using a machine learning analysis shows that the EMSE is a valuable prognostic tool, and appears particularly accurate and effective in identifying patients with 30-day survival, whereas its performance in predicting 30-day mortality is lower and needs to be further improved.
本研究旨在使用机器学习系统,验证基于流行病学的癫痫持续状态死亡率评分(EMSE)预测癫痫持续状态(SE)患者 30 天死亡率的准确性,该评分基于大样本 SE 患者队列。
我们纳入了 2013 年至 2021 年期间在摩德纳学术医院住院的连续 SE 患者。使用 30 天死亡率作为因变量,EMSE 预测因子作为输入变量,进行决策树分析。我们使用接受者操作特征曲线下面积(AUC ROC)评估 EMSE 预测 30 天死亡率的准确性,置信区间为 95%(95%CI)。我们对非缺氧性 SE 进行了亚组分析。
共纳入 698 例 SE 患者,30 天死亡率为 28.9%(202/698)。整个人群的平均 EMSE 值为 57.1(标准差 [SD] = 36.3);与存活患者相比,死亡患者的 EMSE 值更低(47.1,SD = 31.7 与 81.9,SD = 34.8;p < 0.001)。EMSE 对预测 30 天死亡率的准确性较高,AUC ROC 为 0.782(95%CI = 0.747-0.816)。病因是最相关的预测因子,其次是年龄、脑电图(EEG)和 EMSE 合并症 B 组。使用 EMSE 变量的决策树分析正确预测了 77.9%病例的死亡风险;在 SE 后 30 天内,预测结果在存活患者中的准确率为 85.7%,在死亡患者中的准确率为 58.9%。在非缺氧性 SE 中,最相关的预测因子是年龄,其次是 EEG 和 EMSE 合并症 B 组;所有病例的预测准确率为 78.9%(存活患者中为 89.6%,非存活患者中为 46.1%)。
这项使用机器学习分析的验证研究表明,EMSE 是一种有价值的预后工具,在识别 30 天存活患者方面特别准确和有效,而其预测 30 天死亡率的效果较低,需要进一步提高。